Harpoon Therapeutics, Inc. (NASDAQ:HARP) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Rating) have received an average recommendation of “Moderate Buy” from the eight brokerages that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year target […]
Ronald Hunt Piper Sandler Blackrock Inc Harpoon Therapeutics Company Profile Canaccord Genuity Group Millennium Management
Source: themarketsdaily.com